Kelly Wallace Stinson

Kelly Wallace Stinson is an accomplished professional in the fields of clinical research and microbiology, currently serving as the Bioassay Development Lead at the Bill & Melinda Gates Medical Research Institute since October 2022. Stinson has extensive experience, including a consultancy role at Cultura, Incorporated from April 2014 to January 2023, and a tenure at Otsuka Pharmaceutical Co., Ltd from September 2009 to February 2014 as a global clinical manager in microbiology. Prior positions include senior clinical research associate at Otsuka Pharmaceuticals and epidemiologist at the Centers for Disease Control and Prevention. Stinson holds a Master of Public Health in international health from Emory University and a Bachelor of Science in Biology from Georgia State University.